This matching involves understanding the mechanisms of action (MOA) of key anti-tubercular drugs used in the treatment of tuberculosis:
\begin{itemize}
\item Ethambutol — Inhibits arabinosyl transferase, an enzyme essential for the polymerization of arabinogalactan, a crucial component of the mycobacterial cell wall. (1)-(R)
\item Para-aminosalicylic acid (PAS) — Acts as a structural analog of PABA and inhibits folate synthase, thereby interfering with folate metabolism. (2)-(S)
\item Rifampicin — Inhibits DNA-dependent RNA polymerase in mycobacteria, preventing transcription and RNA synthesis. (3)-(P)
\item Bedaquiline — Specifically targets and inhibits the mycobacterial ATP synthase enzyme, leading to depletion of cellular energy (ATP) in Mycobacterium tuberculosis. (4)-(Q)
\end{itemize}
Matching accordingly:
- (1)-(R) Ethambutol
- (2)-(S) Para-aminosalicylic acid
- (3)-(P) Rifampicin
- (4)-(Q) Bedaquiline